261 related articles for article (PubMed ID: 27100297)
1. Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.
Hwang JP; Lim I; Kong CB; Jeon DG; Byun BH; Kim BI; Choi CW; Lim SM
PLoS One; 2016; 11(4):e0153281. PubMed ID: 27100297
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
[TBL] [Abstract][Full Text] [Related]
3. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.
Raciborska A; Bilska K; Drabko K; Michalak E; Chaber R; Pogorzała M; Połczyńska K; Sobol G; Wieczorek M; Muszyńska-Rosłan K; Rychlowska-Pruszyńska M; Rodriguez-Galindo C; Dziuk M
Clin Transl Oncol; 2016 Feb; 18(2):189-95. PubMed ID: 26250765
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of SUVmax measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Pancreatic Cancer.
Hwang JP; Lim I; Chang KJ; Kim BI; Choi CW; Lim SM
Nucl Med Mol Imaging; 2012 Sep; 46(3):207-14. PubMed ID: 24900062
[TBL] [Abstract][Full Text] [Related]
5. Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET.
Sobic Saranovic DP; Nikitovic M; Saponjski J; Grozdic Milojevic I; Paripovic L; Saranovic D; Beatovic S; Artiko VM
Eur J Radiol; 2020 Aug; 129():109076. PubMed ID: 32446127
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
7. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
8. Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Dec; 94(51):e2319. PubMed ID: 26705220
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study.
Hwang JP; Moon JH; Kim HK; Lee MH; Lim CH; Park SB; Yoon JK; Park JM
Medicine (Baltimore); 2021 May; 100(21):e26015. PubMed ID: 34032720
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of SUV
Diao W; Tian F; Jia Z
Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
[TBL] [Abstract][Full Text] [Related]
11. The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.
Shi D; Cai G; Peng J; Li D; Li X; Xu Y; Cai S
BMC Cancer; 2015 Dec; 15():991. PubMed ID: 26689966
[TBL] [Abstract][Full Text] [Related]
12. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
[TBL] [Abstract][Full Text] [Related]
13. Different
El-Hennawy G; Moustafa H; Omar W; Elkinaai N; Kamel A; Zaki I; Farid N; El-Kholy E
Pediatr Blood Cancer; 2020 Nov; 67(11):e28605. PubMed ID: 32706520
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of preoperative positron emission tomography-computed tomography in surgically resected gastric cancer].
Kim KS; Choi SR; Park IC; Koo TH; Kim JM
Korean J Gastroenterol; 2014 Jun; 63(6):348-53. PubMed ID: 24953611
[TBL] [Abstract][Full Text] [Related]
16. Large cell neuroendocrine carcinoma of the lung: CT and FDG PET findings.
Lee KW; Lee Y; Oh SW; Jin KN; Goo JM
Eur J Radiol; 2015 Nov; 84(11):2332-8. PubMed ID: 26279139
[TBL] [Abstract][Full Text] [Related]
17. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma.
Albano D; Dondi F; Schumacher RF; D'Ippolito C; Porta F; Giubbini R; Bertagna F
J Pediatr Hematol Oncol; 2020 Mar; 42(2):e79-e86. PubMed ID: 31135716
[TBL] [Abstract][Full Text] [Related]
19. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC
Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.
Suzuki H; Kato K; Fujimoto Y; Itoh Y; Hiramatsu M; Naganawa S; Hasegawa Y; Nakashima T
Ann Nucl Med; 2014 May; 28(4):356-62. PubMed ID: 24515867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
